Literature DB >> 22782081

Peri-infarct blood-brain barrier dysfunction facilitates induction of spreading depolarization associated with epileptiform discharges.

E G Lapilover1, K Lippmann, S Salar, A Maslarova, J P Dreier, U Heinemann, A Friedman.   

Abstract

Recent studies showed that spreading depolarizations (SDs) occurs abundantly in patients following ischemic stroke and experimental evidence suggests that SDs recruit tissue at risk into necrosis. We hypothesized that BBB opening with consequent alterations of the extracellular electrolyte composition and extravasation of albumin facilitates generation of SDs since albumin mediates an astrocyte transcriptional response with consequent disturbance of potassium and glutamate homeostasis. Here we show extravasation of Evans blue-albumin complex into the hippocampus following cortical photothrombotic stroke in the neighboring neocortex. Using extracellular field potential recordings and exposure to serum electrolytes we observed spontaneous SDs in 80% of hippocampal slices obtained from rats 24 h after cortical photothrombosis. Hippocampal exposure to albumin for 24 h through intraventricular application together with serum electrolytes lowered the threshold for the induction of SDs in most slices irrespective of the pathway of stimulation. Exposing acute slices from naive animals to albumin led also to a reduced SD threshold. In albumin-exposed slices the onset of SDs was usually associated with larger stimulus-induced accumulation of extracellular potassium, and preceded by epileptiform activity, which was also observed during the recovery phase of SDs. Application of ifenprodil (3 μM), an NMDA-receptor type 2 B antagonist, blocked stimulus dependent epileptiform discharges and generation of SDs in slices from animals treated with albumin in-vivo. We suggest that BBB opening facilitates the induction of peri-infarct SDs through impaired homeostasis of K+.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782081      PMCID: PMC3588590          DOI: 10.1016/j.nbd.2012.06.024

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  67 in total

1.  Experimental and preliminary clinical evidence of an ischemic zone with prolonged negative DC shifts surrounded by a normally perfused tissue belt with persistent electrocorticographic depression.

Authors:  Ana I Oliveira-Ferreira; Denny Milakara; Mesbah Alam; Devi Jorks; Sebastian Major; Jed A Hartings; Janos Lückl; Peter Martus; Rudolf Graf; Christian Dohmen; Georg Bohner; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-24       Impact factor: 6.200

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Metabolic challenge to glia activates an adenosine-mediated safety mechanism that promotes neuronal survival by delaying the onset of spreading depression waves.

Authors:  Santiago Canals; Belén Larrosa; Jesús Pintor; María A Mena; Oscar Herreras
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

Review 4.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

5.  Effects of changes in extracellular potassium, magnesium and calcium concentration on synaptic transmission in area CA1 and the dentate gyrus of rat hippocampal slices.

Authors:  G Rausche; P Igelmund; U Heinemann
Journal:  Pflugers Arch       Date:  1990-02       Impact factor: 3.657

6.  Partial disinhibition is required for transition of stimulus-induced sharp wave-ripple complexes into recurrent epileptiform discharges in rat hippocampal slices.

Authors:  Agustin Liotta; Gürsel Caliskan; Rizwan ul Haq; Jan O Hollnagel; Anton Rösler; Uwe Heinemann; Christoph J Behrens
Journal:  J Neurophysiol       Date:  2010-09-29       Impact factor: 2.714

7.  Frequent blood-brain barrier disruption in the human cerebral cortex.

Authors:  O Tomkins; D Kaufer; A Korn; I Shelef; H Golan; E Reichenthal; H Soreq; A Friedman
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 8.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

Authors:  Jens P Dreier
Journal:  Nat Med       Date:  2011-04-07       Impact factor: 53.440

9.  Alterations in the microenvironment during spreading depression associated with epileptiform activity in the immature neocortex.

Authors:  J J Hablitz; U Heinemann
Journal:  Brain Res Dev Brain Res       Date:  1989-04-01

Review 10.  Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.

Authors:  Alon Friedman; Daniela Kaufer; Uwe Heinemann
Journal:  Epilepsy Res       Date:  2009-04-11       Impact factor: 3.045

View more
  26 in total

1.  Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction.

Authors:  Itai Weissberg; Lydia Wood; Lyn Kamintsky; Oscar Vazquez; Dan Z Milikovsky; Allyson Alexander; Hannah Oppenheim; Carolyn Ardizzone; Albert Becker; Federica Frigerio; Annamaria Vezzani; Marion S Buckwalter; John R Huguenard; Alon Friedman; Daniela Kaufer
Journal:  Neurobiol Dis       Date:  2015-03-30       Impact factor: 5.996

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

Review 3.  Photothrombotic Stroke as a Model of Ischemic Stroke.

Authors:  Anatoly B Uzdensky
Journal:  Transl Stroke Res       Date:  2017-11-29       Impact factor: 6.829

Review 4.  Blood-brain barrier imaging in human neuropathologies.

Authors:  Ronel Veksler; Ilan Shelef; Alon Friedman
Journal:  Arch Med Res       Date:  2014-11-29       Impact factor: 2.235

Review 5.  Anatomy and physiology of the blood-brain barrier.

Authors:  Yonatan Serlin; Ilan Shelef; Boris Knyazer; Alon Friedman
Journal:  Semin Cell Dev Biol       Date:  2015-02-11       Impact factor: 7.727

Review 6.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

Review 7.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

8.  Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment.

Authors:  Kae M Pusic; Aya D Pusic; Jordan Kemme; Richard P Kraig
Journal:  Glia       Date:  2014-04-10       Impact factor: 7.452

9.  Monitoring stroke progression: in vivo imaging of cortical perfusion, blood-brain barrier permeability and cellular damage in the rat photothrombosis model.

Authors:  Karl Schoknecht; Ofer Prager; Udi Vazana; Lyn Kamintsky; Denise Harhausen; Marietta Zille; Lena Figge; Yoash Chassidim; Eyk Schellenberger; Richard Kovács; Uwe Heinemann; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

10.  Epileptiform activity and spreading depolarization in the blood-brain barrier-disrupted peri-infarct hippocampus are associated with impaired GABAergic inhibition and synaptic plasticity.

Authors:  Kristina Lippmann; Lyn Kamintsky; Soo Young Kim; Svetlana Lublinsky; Ofer Prager; Julia Friederike Nichtweiss; Seda Salar; Daniela Kaufer; Uwe Heinemann; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.